| The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments S Iyer, R Prajapati, A Ramesh, M Basavalingegowda, S Todur, ... Molecular and Clinical Oncology 10 (4), 469-475, 2019 | 6 | 2019 |
| Algorithm to derive progression-based lines of therapy from a real-world non-small cell lung cancer (NSCLC) dataset. S Agrawal, V Priya, R George, SV Manirevu, T Bhardwaj, R Prajapati, ... Journal of Clinical Oncology 39 (15_suppl), e21172-e21172, 2021 | 1 | 2021 |
| Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale. S Agrawal, R George, VP Vaidya, S Chakkrapani, R Prajapati, S Tankala, ... Journal of Clinical Oncology 41 (16_suppl), 6607-6607, 2023 | | 2023 |
| Machine learning imputation of metastatic status from open claims in melanoma patients. VP Vaidya, R Prajapati, SV Manirevu, R George, S Agrawal, B Narayanan Journal of Clinical Oncology 39 (15_suppl), e21540-e21540, 2021 | | 2021 |
| BRCA- Asian Indian Cohort Finding R Prajapat Reports in Cancer and Treatment, 2018 | | 2018 |
| Liquid Biopsy: Golden Era of Personalized Medicine in Oncology G Shafi, S Iyer, S Desai, M Basavalingegowda, S Kavishwar, R Prajapati, ... | | |
Gowhar ShafiComputational Medicine, Karolinska Institute, Stockholm SwedenVerified email at ki.se
